Accumetrics, Inc., developer of the market-leading VerifyNow® System, announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to ...
May 20, 2011 (San Diego, CA) — The platelet-function test VerifyNow P2Y12 (Accumetrics), has been granted a CE mark in Europe for a new, updated claim for prognostic use to help identify patients with ...
Patients with High Platelet Reactivity had 2.5 Times Greater Rate of Stent Thrombosis at 1-Year. Miami, FL – Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use ...
San Francisco, CA - Absolute and relative levels of platelet inhibition based on a VerifyNow test (Accumetrics) are strong independent predictors of stent thrombosis in patients who have undergone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback